Neurological conditions associated with HIV remain major contributors to morbidity and
mortality and are increasingly recognized in the aging population on long-standing …

The rising prevalence of HIV drug resistance (HIVDR) could threaten gains made in
combating the HIV epidemic and compromise the 90-90-90 target proposed by United …

BACKGROUND Persistence of HIV in sanctuary sites despite antiretroviral therapy (ART)
presents a barrier to HIV remission and may affect neurocognitive function. We assessed …

Background Human immunodeficiency virus type 1 (HIV-1) populations are detected in
cerebrospinal fluid (CSF) of some people on suppressive antiretroviral therapy (ART) …

Background: During antiretroviral therapy, HIV RNA can be detected in cerebrospinal fluid
(CSF) when it is undetectable in plasma, a condition termed 'CSF viral escape'. The aim of …

The longevity of people with HIV/AIDS has been prolonged with the use of antiretroviral
therapy (ART). The age-related complications, especially cognitive deficits, rise as HIV …

Suppression of plasma HIV RNA is most often attainable with effective antiretroviral therapy.
Despite this, in some individuals, detection of HIV RNA remains evident in the cerebrospinal …

Background Neurocognitive impairment (NCI) in people with human immunodeficiency virus
(PWH) remains a concern despite potent antiretroviral therapy (ART). Higher central nervous …

Although treatment with antiretroviral therapy (ART) improves central nervous inflammation,
limits viral replication detected in the cerebrospinal fluid, and prevents severe clinical …

Objective: To review the evidence that CSF (cerebrospinal fluid) escape populations are
produced by viral reservoirs in the central nervous system (CNS). Design: CSF escape is a …